作者: J. C. Schink , C. B. Weldon , J. R. Trosman , A. B. Benson , A. I. Löffler
DOI: 10.1200/JCO.2010.28.15_SUPPL.6146
关键词:
摘要: 6146 Background: Personalized medicine—pharmacogenomics (PGx) and molecular diagnostics (MDx)—improve outcomes by more accurately individualizing treatment to patients. The Institute of Medicine re...